Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Adenocarcinoma of lung, stage IV
CUI: C0854988
Disease: Adenocarcinoma of lung, stage IV
0.040 GeneticVariation BEFREE A 65-year-old Japanese woman was diagnosed with stage IV lung adenocarcinoma with L858R point mutation in exon 21. 29675860 2018
Adenocarcinoma of lung, stage IV
CUI: C0854988
Disease: Adenocarcinoma of lung, stage IV
0.040 GeneticVariation BEFREE Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs. 31289556 2019
Adenocarcinoma of lung, stage IV
CUI: C0854988
Disease: Adenocarcinoma of lung, stage IV
0.040 GeneticVariation BEFREE Patients in stage IV lung adenocarcinoma with MPEs at initial diagnosis have shorter overall survival and higher EGFR mutation rate, especially for L858R, than patients who develop MPEs following disease progression. 23018906 2013
Adenocarcinoma of lung, stage IV
CUI: C0854988
Disease: Adenocarcinoma of lung, stage IV
0.040 GeneticVariation BEFREE We report a case of a 38-year-old woman who was diagnosed with stage IV lung adenocarcinoma, harboring an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790 M mutation on exon 20. 27599705 2017